Saturday 20 January 2018
Contact US    |    Archive
PR
4 months ago

TapImmune Appoints Peter Hoang as President and Chief Executive Officer

JACKSONVILLE, Fla., Sept. 25, 2017 /PRNewswire/ -- TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

TapImmune

 | 

Appoints

 | 

Peter

 | 

Hoang

 | 

President

 | 

and

 | 

Chief

 | 

Executive

 | 

Officer

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries